The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3

Journal of Neurochemistry

Volumn 72, Issue 3, 2000, Pages 1327-1330

  Chen, Guang ^a   Huang, Li Dong ^a   Jiang, Yi Ming ^a   Manji, Husseini K ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Activator protein 1; Gene expression; Glycogen synthase kinase 3 ; Lithium; Manic depression; Valproate; Catenin

Indexed keywords

CASEIN KINASE I; LITHIUM; VALPROIC ACID;

ARTICLE; BINDING AFFINITY; CYTOSKELETON; DNA BINDING; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; MANIC DEPRESSIVE PSYCHOSIS; PHOSPHORYLATION; PRIORITY JOURNAL;

EID: 0033014180     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0721327.x     Document Type: Article

References (24)

1. Asghari V., Wang J. F., Reiach J. S., and Young L. T. (1998) Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY-5Y cells. Mol. Brain Res. 58, 95-102.
2. Atkins C. M., Chen S.-J., Klann E., and Sweatt J. D. (1997) Increased phosphorylation of myelin basic protein during hippocampal long-term potentiation. J. Neurochem. 68, 1960-1967.
3. Bowden C. L., Brugger A. M., Swann A. C., Calabrese J. R., Janicak P. G., Petty F., Dilsaver S. C., Davis J. M., Rush A. J., and Small J. G. (1994) Efficacy of divalproex vs. lithium and placebo in the treatment of mania. JAMA 271, 918-924.
4. Chen G., Yuan P.-X., Hawver D. B., Potter W. Z., and Manji H. K. (1997) Increase in AP-1 transcription factor DNA binding activity by valproic acid. Neuropsychopharmacology 16, 238-245.
5. Chen G., Yuan P.-X., Jiang Y.-M., Huang L.-D., and Manji H. K. (1998) Lithium increases tyrosine hydroxylase levels both in vivo and in vitro. J. Neurochem. 70, 1768-1771.
6. Cross D. A., Alessi D. R., Cohen P., Andjelkovich M., and Hemmings B. A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789.
7. Freeman M. P. and Stoll A. L. (1998) Mood stabilizer combinations: a review of safety and efficacy. Am. J. Psychiatry 155, 12-21.
8. Goode N., Hughes K., Woodgett J. R., and Parker P. J. (1992) Differential regulation of glycogen synthase kinase-3β by protein kinase C isotypes. J. Biol. Chem. 267, 16878-16882.
9. Guitart X. and Nestler E. J. (1992) Chronic administration of lithium or other antidepressants increases levels of DARPP-32 in rat frontal cortex. J. Neurochem. 59, 1164-1167.
10. Hedgepeth C. M., Conrad L. J., Zhang J., Huang H. C., Lee V. M., and Klein P. S. (1997) Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev. Biol. 185, 82-91.
11. Hyman S. E. and Nestler E. J. (1996) Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am. J. Psychiatry 153, 151-162.
12. lkeda S., Kishida S., Yamamoto H., Murai H., Koyama S., and Kikuchi A. (1997) Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin. EMBO J. 17, 1371-1384.
13. Jope R. S. (1999) A bimodal model of the mechanism of action of lithium. Mol. Psychiatry (in press).
14. Jope R. S. and Williams M. B. (1994) Lithium and brain signal transduction systems. Biochem. Pharmacol. 77, 429-441.
15. Klein P. S. and Melton D. A. (1996) A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA 93, 8455-8459.
16. Larabell C. A., Torres M., Rowning B. A., Yost C., Miller J. R., Wu M., Kimelman D., and Moon R. T. (1997) Establishment of the dorso-ventral axis in Xenopus embryos is presaged by early asymmetrics in beta catenin that are modulated by the Wnt signaling pathway. J. Cell Biol. 136, 1123-1136.
17. Lin A., Smeal T., Binetruy B., Deng T., Chambard J. C., and Karin M. (1993) Control of AP-1 activity by signal transduction cascades. Adv. Second Messenger Phosphoprotein Res. 28, 255-260.
18. Lucas F. R. and Salinas P. C. (1997) WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons. Dev. Biol. 192, 31-44.
19. Manji H. K., Potter W. Z., and Lenox R. H. (1995) Signal transduction pathways. Molecular targets for lithium's actions. Arch. Gen. Psychiatry 52, 531-543.
20. Ozaki N. and Chuang D.-M. (1997) Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain. J. Neurochem. 69, 2336-2344.
21. Stambolic V., Laurent R., and Woodgett J. R. (1996) Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr. Biol. 6, 1664-1668.
22. Wagner U., Utton M., Gallo J. M., and Miller C. C. J. (1996) Cellular phosphorylation of tau by GSK-3β influences tau binding to microtubules and microtubule organization. J. Cell Sci. 109, 1537-1543.
23. Yost C., Torres M., Miller J. R., Huang E., Kimelman D., and Moon R. T. (1996) The axis-inducing activity, stability, and subcellular distribution of beta catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev. 10, 1443-1454.
24. Yuan P.-X., Chen G., and Manji H. K. (1998) Lithium stimulates gene expression through the AP-1 transcription factor pathway. Mol. Brain Res. 58, 225-230.